Evogene Ltd. Research And Development Expense

• Evogene Ltd. showed a decrease of -36.1% in Research And Development Expense from 2024 to 2025.
• This data is from Evogene Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 11 years of available data (2015 to 2025), Evogene Ltd.'s Research And Development Expense has declined by 44.7%.
• Historical annual values: Fiscal year 2025: $7.99 million | Fiscal year 2024: $12.51 million | Fiscal year 2023: $16.20 million | Fiscal year 2022: $20.79 million | Fiscal year 2021: $21.13 million | Fiscal year 2020: $17.29 million | Fiscal year 2019: $15.79 million | Fiscal year 2018: $14.69 million | Fiscal year 2017: $16.99 million | Fiscal year 2016: $16.41 million | Fiscal year 2015: $14.45 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026